🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06588127
Active, not recruiting Not applicable

Health Behavior Nudge Strategies for Chronic Disease Patients: the Study of Hypertension and Type 2 Diabetes

NCT06588127 · tracked via the Priya Life Science China tracker
Sponsor
Lin Han
Phase
Not applicable
Started
2024-07-01
Last updated
2024-09-19

Condition(s) studied

Economics, BehavioralHypertensionType 2 Diabetes Mellitus (T2DM)Self-management BehaviorHealth Behavior

Investigational drug(s) / intervention(s)

nudge

nudge: Nudge interventions are developed based on the scoping review and qualitative research by the research team, which involves commitment (behavioral contracts), norms (case and experience sharing), significance and framing effects (posters, health behavior identification posts), reminders, and incentives (arteriosclerosis detection). The content encompasses diet, physical activity, medication management, self-monitoring, and control of smoking and alcohol. From the viewpoint of bounded rationality in behavioral economics, and drawing on prior research that has pinpointed decision-making biases in patients' self-management behaviors, nudging strategies have been developed to assist individuals in overcoming these biases or to utilize the patterns of these biases to steer them toward making choices that are in line with their health.

Study summary

This study is conducted from the perspective of behavioral economics, where individuals often display bounded rationality in decision-making, opting for habitual choices rather than those most advantageous to themselves. Nudge strategies can utilize individuals\' cognitive and motivational shortcomings to influence behavior. Therefore, the study first examines the decision-making biases present in patients with hypertension (HP) and type 2 diabetes mellitus (T2DM) regarding the maintenance of healthy behaviors based on individuals' bounded rationality; subsequently, it develops an intervention program to encourage healthy behaviors in HP and T2DM patients alongside nudge strategies; finally, it assesses the intervention effects of the program on blood pressure, blood glucose, and health behaviors in HP and T2DM patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Age ≥ 18 years * Previously diagnosed with hypertension, type 2 diabetes, or hypertension combined with type 2 diabetes * Able to use mobile phones or other electronic devices * Informed consent Exclusion Criteria: * Patients who are pregnant or breastfeeding; * Patients with severe diabetes, hypertension complications, or other serious illnesses; * Patients with hearing or vision impairments; * Patients with cognitive impairments or mental illnesses; * Patients with acute complications.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
School of nursing, Lanzhou University Lanzhou Gansu

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06588127 on ClinicalTrials.gov ↗ ← All trials in China